Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to Earnings
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Fractyl Health (GUTS) Enterprise Value (2024 - 2026)

Fractyl Health's Enterprise Value history spans 3 years, with the latest figure at -$81.5 million for Q4 2025.

  • For the quarter ending Q4 2025, Enterprise Value fell 20.86% year-over-year to -$81.5 million, compared with a TTM value of -$81.5 million through Dec 2025, down 20.86%, and an annual FY2025 reading of -$81.5 million, down 20.86% over the prior year.
  • Enterprise Value for Q4 2025 was -$81.5 million at Fractyl Health, down from -$77.7 million in the prior quarter.
  • The five-year high for Enterprise Value was -$22.3 million in Q2 2025, with the low at -$121.8 million in Q1 2024.
  • Average Enterprise Value over 3 years is -$70.4 million, with a median of -$77.7 million recorded in 2025.
  • Year-over-year, Enterprise Value plummeted 101.24% in 2024 and then surged 78.3% in 2025.
  • Tracing GUTS's Enterprise Value over 3 years: stood at -$33.5 million in 2023, then plummeted by 101.24% to -$67.5 million in 2024, then decreased by 20.86% to -$81.5 million in 2025.
  • Per Business Quant, the three most recent readings for GUTS's Enterprise Value are -$81.5 million (Q4 2025), -$77.7 million (Q3 2025), and -$22.3 million (Q2 2025).